Amalgamated Bank’s Disc Medicine IRON Stock Holding History

Amalgamated Bank’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-784	Closed	-$62K	–	2219
2025 Q4	$62K	Sell	784 -3	-0.4%	-$253	﹤0.01%	1782
2025 Q3	$52K	Hold	787	–	–	﹤0.01%	1828
2025 Q2	$42K	Hold	787	–	–	﹤0.01%	1868
2025 Q1	$39K	Buy	787 +219	+39%	+$12.2K	﹤0.01%	1848
2024 Q4	$36K	Hold	568	–	–	﹤0.01%	1922
2024 Q3	$28K	Hold	568	–	–	﹤0.01%	2011
2024 Q2	$26K	Buy	568 +247	+77%	+$8.39K	﹤0.01%	2032
2024 Q1	$20K	Sell	321 -964	-75%	-$62.5K	﹤0.01%	2126
2023 Q4	$74K	Buy	1,285 +140	+12%	+$7.17K	﹤0.01%	2104
2023 Q3	$54K	Hold	1,145	–	–	﹤0.01%	2222
2023 Q2	$51K	Buy	+1,145	New	+$40.6K	﹤0.01%	2312
2022 Q2	–	Sell	-97	Closed	-$4K	–	3119
2022 Q1	$4K	Buy	+97	New	+$5.09K	﹤0.01%	3034

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Amalgamated Bank's IRON Position: Q1 2026 in Review

Amalgamated Bank sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 784 shares — an estimated $62K sold.

Amalgamated Bank first reported a position in IRON in Q1 2022 and held it in 12 quarters. The position peaked at $74K in Q4 2023. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

Amalgamated Bank reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 784 Disc Medicine shares in Q1 2026, an estimated $62K.
Amalgamated Bank first reported a position in Disc Medicine in Q1 2022 and held it in 12 quarters.
Amalgamated Bank's Disc Medicine position peaked at $74K in Q4 2023.
203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.